FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to medicine, namely ophthalmology, and aims at treating cataract. A drug preparation for treating cataract based on the active substance sodium dihydroazapentacene polysulphonate (azapentacene) is presented in the form of ophthalmic drops. Stabilising is ensured by using a borate buffer and potassium chloride, a borate buffer and sodium chloride, a phosphate buffer, a quaternary ammonium derivative, Nipaging and a preserving agent of mercury derivatives. The ingredients are used in the declared amounts.
EFFECT: using the group of inventions provides the enhanced antimicrobial properties and the reduced toxicity of the ophthalmic drops, thereby increasing the clinical effectiveness in cataract.
6 cl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION CONTAINING AZAPENTACENE (VERSIONS) | 2014 |
|
RU2571279C1 |
IMPROVED EYE DROPS FOR PREVENTION AND TREATMENT OF EARLY MANIFESTATIONS OF AGE-RELATED NUCLEAR CATARACT | 2020 |
|
RU2748598C1 |
EYE DROPS FOR TREATING AGE-RELATED NUCLEAR CATARACT | 2019 |
|
RU2720676C2 |
COMBINED OPHTHALMIC AGENT | 2019 |
|
RU2733392C1 |
OPHTHALMIC DROP "KARNOSIN" | 2001 |
|
RU2201213C1 |
OPHTHALMIC DROPS "INTERPAN" | 2001 |
|
RU2196588C1 |
OPHTHALMIC COMPOSITION | 2017 |
|
RU2749723C2 |
Pharmaceutical composition based on tramadol for ophthalmic use | 2016 |
|
RU2744570C2 |
METHOD OF TREATING INFLAMMATORY EYE DISEASES IN HUMAN AND ANIMALS FOR STIMULATION OF REPAIR PROCESSES AND EPITHELISATION | 2011 |
|
RU2470630C1 |
DROPS FOR TREATING OCULAR HYPERTENSION AND GLAUCOMA, AND METHOD FOR PREPARING SAID DROPS | 1995 |
|
RU2099049C1 |
Authors
Dates
2014-12-27—Published
2012-11-14—Filed